These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 24656928)

  • 1. Early events in Sjögren's Syndrome pathogenesis: the importance of innate immunity in disease initiation.
    Kramer JM
    Cytokine; 2014 Jun; 67(2):92-101. PubMed ID: 24656928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate immunity in Sjögren's syndrome.
    Kiripolsky J; McCabe LG; Kramer JM
    Clin Immunol; 2017 Sep; 182():4-13. PubMed ID: 28396235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro-inflammatory cytokines enhance ERAD and ATF6α pathway activity in salivary glands of Sjögren's syndrome patients.
    Barrera MJ; Aguilera S; Castro I; Cortés J; Bahamondes V; Quest AFG; Molina C; González S; Hermoso M; Urzúa U; Leyton C; González MJ
    J Autoimmun; 2016 Dec; 75():68-81. PubMed ID: 27461470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of functional Toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjögren's syndrome.
    Spachidou MP; Bourazopoulou E; Maratheftis CI; Kapsogeorgou EK; Moutsopoulos HM; Tzioufas AG; Manoussakis MN
    Clin Exp Immunol; 2007 Mar; 147(3):497-503. PubMed ID: 17302899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocols for Experimental Sjögren's Syndrome.
    Bagavant H; Deshmukh US
    Curr Protoc Immunol; 2020 Dec; 131(1):e114. PubMed ID: 33252847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
    Jonsson R; Vogelsang P; Volchenkov R; Espinosa A; Wahren-Herlenius M; Appel S
    Immunol Lett; 2011 Dec; 141(1):1-9. PubMed ID: 21777618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sjögren's syndrome. Controversies and progress.
    Fox RI
    Clin Lab Med; 1997 Sep; 17(3):431-44. PubMed ID: 9316767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sjögren's syndrome.
    Delaleu N; Jonsson R; Koller MM
    Eur J Oral Sci; 2005 Apr; 113(2):101-13. PubMed ID: 15819815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate Immunity and Biological Therapies for the Treatment of Sjögren's Syndrome.
    Srivastava A; Makarenkova HP
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33271951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjögren's syndrome.
    Matsumoto I; Tsubota K; Satake Y; Kita Y; Matsumura R; Murata H; Namekawa T; Nishioka K; Iwamoto I; Saitoh Y; Sumida T
    J Clin Invest; 1996 Apr; 97(8):1969-77. PubMed ID: 8621782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of cleaved alpha-fodrin autoantigen in Sjögren's syndrome: apoptosis and co-localisation of cleaved alpha-fodrin with activated caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP) in labial salivary glands.
    Wang Y; Virji AS; Howard P; Sayani Y; Zhang J; Achu P; McArthur C
    Arch Oral Biol; 2006 Jul; 51(7):558-66. PubMed ID: 16405863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of dendritic cells in Sjögren's syndrome.
    Vogelsang P; Jonsson MV; Dalvin ST; Appel S
    Scand J Immunol; 2006 Sep; 64(3):219-26. PubMed ID: 16918690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the Innate Immunity Signaling Pathway in the Pathogenesis of Sjögren's Syndrome.
    Shimizu T; Nakamura H; Kawakami A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary mucins induce a Toll-like receptor 4-mediated pro-inflammatory response in human submandibular salivary cells: are mucins involved in Sjögren's syndrome?
    Barrera MJ; Aguilera S; Veerman E; Quest AF; Díaz-Jiménez D; Urzúa U; Cortés J; González S; Castro I; Molina C; Bahamondes V; Leyton C; Hermoso MA; González MJ
    Rheumatology (Oxford); 2015 Aug; 54(8):1518-27. PubMed ID: 25802401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sjögren's syndrome salivary gland immunopathology: increased laminin expression precedes lymphocytic infiltration.
    McArthur CP; Daniels PJ; Kragel P; Howard PF; Julian L
    J Autoimmun; 1997 Feb; 10(1):59-65. PubMed ID: 9080300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of plasmacytoid dendritic cells by apoptotic particles - mechanism for the loss of immunological tolerance in Sjögren's syndrome.
    Ainola M; Porola P; Takakubo Y; Przybyla B; Kouri VP; Tolvanen TA; Hänninen A; Nordström DC
    Clin Exp Immunol; 2018 Mar; 191(3):301-310. PubMed ID: 29105068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjögren's syndrome.
    Nakamura H; Kawakami A; Eguchi K
    Transl Res; 2006 Dec; 148(6):281-8. PubMed ID: 17162248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sjögren's syndrome and the epithelial target: a comprehensive review.
    Barrera MJ; Bahamondes V; Sepúlveda D; Quest AF; Castro I; Cortés J; Aguilera S; Urzúa U; Molina C; Pérez P; Ewert P; Alliende C; Hermoso MA; González S; Leyton C; González MJ
    J Autoimmun; 2013 May; 42():7-18. PubMed ID: 23497939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell toll-like receptors with respect to the pathogenesis of Sjögren's syndrome.
    Berglová I; Krejsek J; Kolácková M; Slezák R
    Acta Medica (Hradec Kralove); 2011; 54(2):51-7. PubMed ID: 21842717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and Emerging Evidence for Toll-Like Receptor Activation in Sjögren's Syndrome.
    Kiripolsky J; Kramer JM
    J Immunol Res; 2018; 2018():1246818. PubMed ID: 30671484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.